This lack of toxicity in preclinical and clinical settings is due to the tumor-specific expression of PRL3 protein, which is largely absent in normal human adult tissues,15 with PRL3 mRNA detected only in skeletal and cardiac muscle.18 This evidence concerns the gene PTP4A3 and neoplasm.